BRAF inhibitor shows promising results in pediatric patients with low-grade glioma
Dabrafenib (Tafinlar), a BRAF inhibitor approved to treat certain types of adult melanoma, showed ac...
Popular heartburn drugs may up odds of stomach bug
(HealthDay)—If you’re one of the millions ...
US-born residents more than five times likely to use prescription opioids than new immigrants
The longer immigrants live in the United States, t...
Antidepressant doesn’t ease obsessive behaviors of autism
(HealthDay)—The commonly used antidepressant Pro...
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers
RESILIENT was a single arm, open label, phase II/I...
Retail giant Walmart halts sales of Zantac and related drugs
Walmart has become the latest store to halt sales ...
Laboratory to join ATOM to transform drug discovery with AI
According to the National Cancer Institute, approx...
Drug rediscovery protocol allows doctors to prescribe anticancer drugs outside of their approved use
A large team of researchers affiliated with instit...
UK medical drug supply still uncertain in a no-deal Brexit
Britain’s government watchdog says thereR...
Ritalin at 75: What does the future hold?
Seventy-five years ago, a new stimulant drug with ...
